Asthma Clinical Trial
Official title:
Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
The purpose of this study is to retrofit the existing electronic stethoscope, improve the quality and efficiency of signal acquisition and the intelligent degree of information processing, decrease the manual action of electronic stethoscopes implemented by parents of asthma children, simplify the process of data transfer and the user's operational cost using signal processing, artificial intelligence technology, thus decreasing the feedback cycle between patients and clinicians. Eventually, we will construct an intelligent monitoring system based on the modified electronic stethoscope and explore the interactive remote management approaches on children's asthma at the same time, thus achieving revolutionized remote management of asthma.
| Status | Recruiting |
| Enrollment | 208 |
| Est. completion date | December 31, 2025 |
| Est. primary completion date | December 31, 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 3 Years to 6 Years |
| Eligibility | Inclusion Criteria: 1. Diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" in the respiratory clinic of Shanghai Children's Medical Center from January 2023 to January 2025 2. Out-patient, female or male, 3 years old= age < 6 years old 3. long-term maintenance therapy with inhaled glucocorticoids or concomitant leukotriene receptor antagonists 4. Equipped with a household atomizer or spacer, it can afford the inhalation therapy of short-acting ß2 receptor agonists (SABA) at home 5. The subjects or subjects' caregiver must have a smart phone with Android or Harmony system at their disposal 6. The guardian agrees to participate in the study and signs the informed consent form Exclusion Criteria: 1. Acute exacerbation of asthma 30 days before enrollment (receive short-term prednisone treatment, emergency department visit or hospitalization due to acute asthma attacks) 2. Other chronic lung diseases, cardiovascular diseases, blood system diseases, immunodeficiency diseases, neurological diseases, genetic or chromosomal abnormalities and other underlying diseases 3. Patients or their caregivers can't complete the collection of breath sound |
| Country | Name | City | State |
|---|---|---|---|
| China | Shanghai Children's Medical Center | Shanghai | Shanghai |
| Lead Sponsor | Collaborator |
|---|---|
| Shanghai Children's Medical Center |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | SABA use | Number of days and total amount of SABA use will be collected by investigator through questionnaire. | 1 year | |
| Other | systemic corticosteroid use | Days of systemic corticosteroid use will be counted by investigator through questionnaire. | 1 year | |
| Other | lung function | Subjects (equal or older than 4 years) will receive PEF (Peak expiratory flow, L/min) tests for evaluation of lung function. | 1 year | |
| Other | FENO tests | Subjects will receive FENO (Fractional exhaled nitric oxide, parts per billion, ppb) tests for evaluation of lung inflammation level. | 1 year | |
| Other | Asthma-related medical expenses | Asthma-related medical expenses will be counted by investigator through questionnaire. | 1 year | |
| Other | Asthma-related hospitalizations | Number of asthma-related hospitalizations will be collected by investigator through questionnaire. | 1 year | |
| Other | Missed school and parents missed work | Number of missed school and parents missed work will be collected by investigator through questionnaire. | 1 year | |
| Other | Patients' and caregivers' quality of life | Patients' and caregivers' quality of life will be evaluated by investigator through questionnaire. | 1 year | |
| Other | Caregivers' satisfaction degree with electronic stethoscopes | Caregivers' satisfaction degree with electronic stethoscopes will be assessed by investigators through questionnaire. | 1 year | |
| Primary | visits of asthma-related unplanned emergency department | Subjects will fill out a questionnaire to provide the number of unscheduled emergency department visits related to asthma (except for routine asthma follow-up visits every 3 months). | 1 year | |
| Secondary | asthma control | The patients' caregiver will be prompted to fill out an asthma control questionnaire every month. This questionnaire contains questions regarding renewal of prescription, control status and asthma attack. | 1 year | |
| Secondary | adherence to asthma treatment | Patients' adherence will be assessed by investigator through questionnaire. | 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|